SCHEMBL7098467

SCHEMBL7098467

Nc1cccc(OS(=O)(=O)c2c(F)c(F)c(F)c(F)c2F)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.49
HSP90AA1 P07900 1/20 0.49
MAPT P10636 1/20 0.49
CA1 P00915 5/20 0.46
CA2 P00918 5/20 0.46
CYP3A4 P08684 3/20 0.43
ALDH1A1 P00352 3/20 0.43
CA9 Q16790 2/20 0.43
MAOB P27338 2/20 0.42
TP53 P04637 1/20 0.40
LMNA P02545 1/20 0.39
CA12 O43570 2/20 0.38
CA7 P43166 1/20 0.38
CA13 Q8N1Q1 1/20 0.38
CA4 P22748 1/20 0.38
CA14 Q9ULX7 1/20 0.38
PKM P14618 2/20 0.37
APP P05067 1/20 0.37
TSHR P16473 1/20 0.37
HSD17B10 Q99714 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3790743 0.78 CA1 (0.49) CA1CA2ALDH1A1CA9MAOB
SCHEMBL29673555 0.78 LMNA (0.49) MAPTCA1CA2CYP3A4ALDH1A1
SCHEMBL22187461 0.78 LMNA (0.49) MAPTCA1CA2CYP3A4ALDH1A1
SCHEMBL19834314 0.77 LMNA (0.57) POLBCA1CA2CYP3A4ALDH1A1
SCHEMBL31408860 0.77 CA1 (0.50) POLBHSP90AA1MAPTCA1CA2
SCHEMBL3113873 0.76 CA1 (0.54) POLBHSP90AA1MAPTCA1CA2
SCHEMBL31620700 0.76 CA1 (0.54) POLBHSP90AA1MAPTCA1CA2
SCHEMBL6666074 0.76 ALDH1A1 (0.55) POLBCA1CA2CYP3A4ALDH1A1
Hydrochloric Acid SCHEMBL8641512 0.76 LMNA (0.55) POLBHSP90AA1MAPTCA1CA2
SCHEMBL19470809 0.76 HTR6 (0.47) MAPTCA1CA2CYP3A4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1339668-A2 BISUBSTITUTED CARBOCYCLIC CYCLOPHILIN BINDING COMPOUNDS AND THEIRUS GUILFORD PHARMACEUTICALS INC. (US) 2003-09-03 EP disclosed
US-20020127605-A1 Bisubstituted carbocyclic cyclophilin binding compounds and their use GUILFORD PHARMACEUTICALS, INC. 2002-09-12 US disclosed
WO-2002044126-A2 BISUBSTITUTED CARBOCYCLIC CYCLOPHILIN BINDING COMPOUNDS AND THEIRUS GUILFORD PHARMACEUTICALS INC. (US) 2002-06-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020127605-A1 Bisubstituted carbocyclic cyclophilin binding compounds and their use PPIG, PIN1, PPIH POLB 1913/4885HSP90AA1 513/4885MAPT 1168/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.